Inventor

THO V. THIEU

Inventor

Overview

3→

Patents

2023–2026

Patent span

Chemistry

Primary field (CPC C)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds50%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%

C07BGeneral methods of organic chemistry17%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%

PatentTitleYear

12,545,677Compounds useful as factor XIa inhibitors2026 11,919,881Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors2024 11,814,364Pyridine N-oxide derivatives useful as factor XIa inhibitors2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to JANSSEN PHARMACEUTICA NV (3)· patent assignee history

2023–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
JANSSEN PHARMACEUTICA NV	3	2023–2026

Locations

Location	Patents	Span
US	3	2023–2026